Resources
BNET Business Dictionary
- Endpoint
- a point at which a definable event in a study takes place, for example, the recovery of a patient in a medical study
- Endpoint definition on BNET »
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- i2Telecom Receives Notice of Allowance from U.S. Patent and Trademark Office for "Dynamic Transmission of Packets Over Broadband" Patent
- Patent Covers Technology Utilized by OEMs and Communication Services Providers; Company Believes Patent Substantially Exceeds Value of VoiceStick([R]) Patent Previously Sold for $6.5 Million ATLANTA -- i2Telecom International, Inc. ("i2Telecom([R])") (OTCBB: ITUI), a leading developer of award-winning patented and innovative high-quality mobile applications products and services, today announced that...
- Research articles 2008-10-14
- etrials Worldwide to Report Second Quarter 2008 Financial Results
- MORRISVILLE, N.C. -- etrials([R]) Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint will release financial results for the three months ended June 30, 2008 on Tuesday,...
- Research articles 2008-08-01
- Improved Technology and Unified Communications Create a Case for Videoconferencing Infrastructure
- PALO ALTO, Calif. -- From siloed solutions, conferencing is rapidly evolving to be included along with technologies such as data, collaboration, secure instant messaging, unified messaging, and VoIP to form a complete solution. The emergence of total unified communications UC is transforming videoconferencing's long-standing status as a niche technology for...
- Research articles 2008-05-20
- etrials Worldwide to Report First Quarter 2008 Financial Results
- MORRISVILLE, N.C. -- etrials([R]) Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, today announced that it will release financial results for the three months ended March...
- Research articles 2008-05-05
- Inspire to Discontinue Development of Epinastine Nasal Spray
- DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis SAR did not meet its primary endpoint. "Our analysis of the overall data in this program and the current competitive environment in allergic...
- Research articles 2008-04-23
- Research and Markets: World Network Access Control Technologies Markets Report Views NAC as a Solution Framework That Enables Organizations to Protect the Endpoint
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c88442) announces the addition of new Frost & Sullivan report "World Network Access Control Technologies Markets" to their offering. Frost & Sullivan does not view NAC as a market of point devices or licenses that are sold and easily counted. Instead Frost &...
- Research articles 2008-04-11
- Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
- TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that its Phase 3 clinical trial evaluating the Company's exclusively-licensed technology from the Mayo Clinic consisting of an intranasal antifungal lavage, SinuNase[TM] (topical amphotericin B 0.01% suspension) achieved, as anticipated, superior resolution of the cardinal symptoms of chronic sinusitis CS, as...
- Research articles 2008-03-24
- etrials Worldwide to Report Fourth Quarter and Full Year 2007 Financial Results
- MORRISVILLE, N.C. -- etrials([R]) Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, today announced that it will release financial results for the three months and fiscal...
- Research articles 2008-02-21
- Future Bulls ADMD, AVNR and EPCT.
- M2 PRESSWIRE-3 May 2007-AheadoftheBulls.com: Future Bulls ADMD, AVNR and EPCTC1994-2007 M2 COMMUNICATIONS LTD RDATE:03052007 New York-AheadoftheBulls.com, announces the following companies as high potential, Future Bulls: Advanced Medical Iso (Pink Sheets: ADMD), Avanir Pharmaceuticals (NASDAQ GM: AVNR) and EpiCept Corporation (NASDAQ ...
- Research articles 2007-05-03
- Nabi Biopharmaceuticals Announces Results of Phase IIb Trial of NicVAX.
- M2 PRESSWIRE-2 May 2007-Making The Watchlist: Nabi Biopharmaceuticals Announces Results of Phase IIb Trial of NicVAXC1994-2007 M2 COMMUNICATIONS LTD RDATE:02052007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of...
- Research articles 2007-05-02
- Barrier Therapeutics Announces Positive Results From Azoline Study.
- M2 PRESSWIRE-27 March 2007-Top Of Our Radar: Barrier Therapeutics Announces Positive Results From Azoline StudyC1994-2007 M2 COMMUNICATIONS LTD RDATE:27032007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the...
- Research articles 2007-03-27
- Bit9 FileAdvisor™ Draws More Than 120,000 Unique Visitors from 68 Countries in First Six Weeks of Service; Database of Executable Files Grows to 5 Terabytes; Free Service Identifies Unknown Files, Transforming the Way You Deal with New Software
- CAMBRIDGE, Mass. -- Bit9, Inc., which solves the problem of unwanted software at the endpoint, today disclosed the results of the first six weeks of its new FileAdvisor service (http://fileadvisor.bit9.com). Bit9 FileAdvisor is the first free search engine for identifying software files on any WindowsR computer. In the first six...
- Research articles 2006-05-08
- Bradford Networks Collaborates with Aruba Networks to Develop Aruba Endpoint Compliance System
- Extends Aruba's NAC capabilities with advanced identity, endpoint, and policy tools
- Research articles 2007-08-24
- Immunomedics posts positive data of its experimental cancer drug and Medicure meets primary endpoints in Phase II diabetic hypertension study.
- M2 PRESSWIRE-22 September 2005-US Financial Network: Immunomedics posts positive data of its experimental cancer drug and Medicure meets primary endpoints in Phase II diabetic hypertension studyC1994-2005 M2 COMMUNICATIONS LTD RDATE:22092005 City of Industry, CA - Biotechnology industry news provided by ...
- Research articles 2005-09-22
- Dominican University of California Stops Network Attacks With Mirage Networks; Deploys 'Virtually-Inline' Appliance for Network-based Endpoint Control
- AUSTIN, Texas -- Mirage Networks, Inc., the pioneer in security solutions for Interior Network Defense, today announced that Dominican University of California has deployed CounterPointTM to stop rapidly propagating threats from impacting the university network. Mirage Networks' virtually-inline appliance identifies and contains malicious traffic without interrupting normal campus communications. Student,...
- Research articles 2004-12-08
- Eyes and ears everywhere: extending the network to deeply embedded devices becomes a reality with low-cost wireless transceivers.(design feature)
- THE RANGE OF APPLICATIONS for embedded networks is growing as costs drop, considering that manual device management can be extremely labor-intensive. Industrial sensor networks are the foundation of this technology, as are control applications, such as for lighting control. New applications include supply-chain management, in which...
- Research articles 2004-01-22
- Immunicon Achieves Endpoint in its Pivotal Clinical Trial in Metastatic Androgen-Independent Prostate Cancer
- HUNTINGDON VALLEY, Pa. -- Immunicon Corporation (NASDAQ-GM:IMMC) announced today that the Company met its primary endpoint associated with its pivotal clinical trial in metastatic androgen-independent prostate cancer. The primary endpoint was that circulating tumor cells CTC levels three-to-five weeks after the initiation of chemotherapy would predict overall survival. The study...
- Research articles 2007-01-18
- Immunicon Achieves Endpoints in its Pivotal Clinical Trial in Metastatic Colorectal Cancer
- HUNTINGDON VALLEY, Pa. -- Immunicon Corporation (NASDAQ-GM:IMMC) announced today that the Company met the primary and secondary endpoints associated with its pivotal clinical trial in metastatic colorectal cancer. The primary endpoint was that the number of circulating tumor cells CTCs 3-5 weeks after the initiation of therapy would agree with...
- Research articles 2006-09-26
- CombinatoRx Reports Preliminary Data for Drug Candidate CRx-119 in an Exploratory Immuno-Inflammatory Disease Model; Does Not Meet Primary Endpoint of Reduction of C-Reactive Protein, Analysis of Cytokines is Ongoing
- CAMBRIDGE, Mass. -- CombinatoRx, Incorporated (NASDAQ: CRXX) today announced preliminary results of its randomized, blinded, placebo-controlled clinical trial of CRx-119 in patients with chronic adult periodontitis, an immuno-inflammatory disease model. This study was designed as an exploratory study to allow CombinatoRx to compare and contrast the immuno-inflammatory properties of our...
- Research articles 2006-04-07
- Indevus Announces Positive Phase III Results With Trospium in Overactive Bladder
- Business Editors & Health/Medical Writers LEXINGTON, Mass.--BUSINESS WIRE--Sept. 24, 2002 Trospium Reduces Frequency of Urination and Incontinence Episodes, Achieves All Primary and Secondary Protocol-Defined Endpoints Company Plans to File New Drug Application Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced that its Phase III clinical trial...
- Research articles 2002-09-24
- << Previous
- page 1 of 3
- Next >>
Content Types
Refining Tags
- patient (8 results)
- Security (8 results)
- Nasdaq Stock Market Inc. (7 results)
- Company (6 results)
- FDA (5 results)
- FINANCE (5 results)
- network (4 results)
- Healthcare (4 results)
- Call Transcript (3 results)
- Earnings (3 results)
- Seeking Alpha (3 results)
- NETWORKING (3 results)
- Government (3 results)
- wireless (3 results)
- Web (3 results)
- financial (3 results)
